Proactive Investors - Run By Investors For Investors

Shorts to hike positions in cannabis majors Canopy Growth, Aurora Cannabis, Cronos Group and Tilray, says S3 Partners

Short-sellers are betting on a reversal in what they see as an overheated, overvalued cannabis sector
Tilray product
Tilray and other cannabis stocks should draw more short-selling

Short trading in cannabis stocks is seen increasing further in the major companies of the sector because they remain a profitable, if expensive, bet for market players, a report by analytics company S3 Partners said Friday.

"We can expect more momentum short trading in the more largely shorted, more liquid and larger capitalized securities such as Canopy Growth Corp (NYSE:CGC), Aurora Cannabis Inc (NYSE:ACB), Cronos Group Inc (NASDAQ:CRON) and Tilray Inc (NASDAQ:TLRY)," said a report by Ihor Dusaniwsky, the managing director of Predictive Analytics at S3 Partners, a company that specializes in research on the short side of the market.

The rally in the cannabis sector in 2018 prompted short sellers to add billions of dollars of exposure since the middle of the year, as they bet on a reversal in what they feel is an overheated and overvalued sector.

"Short interest is now $3.35 billion in the 141 securities we track in our cannabis basket. While short interest in the sector continues to grow in 2018, exposure is very extremely concentrated, with 94% of the short interest in only 10 securities," said Dusaniwsky.

The cannabis sector gyrated sharply this week, rallying over 8% Wednesday on news that Attorney General Jeff Sessions' resignation would lead to a loosening of US cannabis policy. A day later, the stocks gave back most of their gains after investors realized immediate changes to the policy was not coming soon.

READ: Tilray shorts fell by about 45,000 in the past week, says S3 Partners

Short-selling the sector is profitable, but the cost to borrow the stock is steep, with the average borrow fee in the sector at 13.44% and short-sellers spending heavily for financing costs. The fee in other companies would usually be seen at much lower levels.

The rate to borrow Tilray stock is a 38% fee and that for Cronos is a 42% fee.

"We should expect short-selling in the cannabis sector to continue to grow, providing a slight counterbalance to the long buying frenzy and also providing trading liquidity in some of the less broadly traded securities," said Dusaniwsky.

He added: "As price volatility and momentum continues to increase in the sector, short sellers will become more active entering and exiting their positions as shorter term trades become larger Alpha generators."

Reporting by Rene Pastor, contactable on [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full WEED profile View Profile

Canopy Growth Corporation Timeline

Related Articles

The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 31 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
Sydney Harbour Bridge
January 23 2019
A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.
cannabis plant
March 09 2019
The Vancouver company's recent move into Jamaica, which covers the acquisition of 145 acres of cultivation property, will pave the way for the development of cannabis brands for the island nation

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use